• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿道透明细胞癌的流行病学及手术在其治疗中的作用

The epidemiology and role of surgery in the treatment of urethral clear cell carcinoma.

作者信息

Patel Mausam, Im Jay, Ivy Austin, Maraboyina Sanjay, Kim Thomas

机构信息

Department of Radiation Oncology, University of Arkansas for Medical Sciences, 4301 West Markham St, Slot 771, Little Rock, AR, 72205, USA.

出版信息

Int Urol Nephrol. 2020 Jan;52(1):51-57. doi: 10.1007/s11255-019-02289-w. Epub 2019 Sep 25.

DOI:10.1007/s11255-019-02289-w
PMID:31555949
Abstract

PURPOSE

To perform a retrospective analysis of the epidemiology and role of surgery on survival in patients with urethral clear cell carcinoma (UCCC) using the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) database.

METHODS

UCCC cases diagnosed from January 1, 1973, to December 31, 2014, were extracted from SEER. Descriptive statistics were calculated for all variables. Univariate analysis to assess for differences in survival with respect to covariates was performed using the log-rank test. Multivariate analysis was performed with Cox proportional hazards regression models to determine the predictive performance of covariates with respect to overall survival (OS) and disease-specific survival (DSS), reported as hazard ratio (HR) with 95% CIs. Comparisons were considered statistically significant at P < 0.05.

RESULTS

Sixty-one cases were extracted for analysis. Mean age ± SD was 63.0 ± 13.9 years. Fifty (82%), 18 (29.5%), and 14 (23.0%) patients underwent surgery, radiation, and chemotherapy, respectively. On univariate analysis, the following covariates were associated with both OS and DSS: age, stage, and surgery (all P < 0.001). On multivariate analysis, surgery was a predictor for improved OS and DSS (HR, 0.178; 95% CI [0.068; 0.464]) and HR, 0.166; 95% CI [0.057; 0.484], respectively). Neither radiation nor chemotherapy was significantly associated with OS or DSS.

CONCLUSION

Surgery was associated with improved OS and DSS in patients with UCCC. While neither radiation nor chemotherapy was significantly associated with survival, additional studies are necessary to determine how these therapeutic interventions may impact prognosis.

摘要

目的

利用美国国立癌症研究所的监测、流行病学和最终结果(SEER)数据库,对尿道透明细胞癌(UCCC)患者的流行病学及手术对生存的作用进行回顾性分析。

方法

从SEER数据库中提取1973年1月1日至2014年12月31日诊断的UCCC病例。对所有变量进行描述性统计。使用对数秩检验进行单因素分析,以评估协变量在生存方面的差异。采用Cox比例风险回归模型进行多因素分析,以确定协变量对总生存(OS)和疾病特异性生存(DSS)的预测性能,结果以风险比(HR)及95%置信区间(CI)表示。P < 0.05时认为差异具有统计学意义。

结果

共提取61例病例进行分析。平均年龄±标准差为63.0±13.9岁。分别有50例(82%)、18例(29.5%)和14例(23.0%)患者接受了手术、放疗和化疗。单因素分析显示,以下协变量与OS和DSS均相关:年龄、分期和手术(均P < 0.001)。多因素分析显示,手术是OS和DSS改善的预测因素(HR分别为0.178;95%CI[0.068;0.464])和HR为0.166;95%CI[0.057;0.484])。放疗和化疗均与OS或DSS无显著相关性。

结论

手术与UCCC患者的OS和DSS改善相关。虽然放疗和化疗均与生存无显著相关性,但仍需进一步研究以确定这些治疗干预措施如何影响预后。

相似文献

1
The epidemiology and role of surgery in the treatment of urethral clear cell carcinoma.尿道透明细胞癌的流行病学及手术在其治疗中的作用
Int Urol Nephrol. 2020 Jan;52(1):51-57. doi: 10.1007/s11255-019-02289-w. Epub 2019 Sep 25.
2
Patterns of Care, Predictors, and Outcomes of Adjuvant Therapy for Early- and Advanced-Stage Uterine Clear Cell Carcinoma: A Population-Based Analysis.早期和晚期子宫透明细胞癌辅助治疗的护理模式、预测因素及结果:一项基于人群的分析
Int J Gynecol Cancer. 2016 May;26(4):697-704. doi: 10.1097/IGC.0000000000000661.
3
Prognostic determinants and treatment outcomes analysis of osteosarcoma and Ewing sarcoma of the spine.脊柱骨肉瘤和尤因肉瘤的预后决定因素及治疗结果分析
Spine J. 2017 May;17(5):645-655. doi: 10.1016/j.spinee.2016.11.002. Epub 2016 Nov 14.
4
Prognostic determinants in patients with uterine and ovarian clear cell carcinoma: a SEER analysis.子宫和卵巢透明细胞癌患者的预后决定因素:SEER 分析。
Gynecol Oncol. 2013 Nov;131(2):404-9. doi: 10.1016/j.ygyno.2013.08.029. Epub 2013 Sep 1.
5
Oncologic benefit of tonsillectomy in stage I and II tonsil cancer: a surveillance epidemiology and end results database review.扁桃体癌 I 期和 II 期行扁桃体切除术的肿瘤学获益:监测流行病学和最终结果数据库回顾。
JAMA Otolaryngol Head Neck Surg. 2013 Apr;139(4):362-6. doi: 10.1001/jamaoto.2013.107.
6
The Impact of Epidemiological Factors and Treatment Interventions on Survival in Patients With Signet Ring Cell Carcinoma of the Pancreas.流行病学因素和治疗干预对胰腺印戒细胞癌患者生存的影响
Am J Clin Oncol. 2018 Dec;41(12):1176-1184. doi: 10.1097/COC.0000000000000447.
7
Primary tumor surgery improves survival in non-metastatic primary urethral carcinoma patients: a large population-based investigation.原发肿瘤手术可改善非转移性原发性尿道癌患者的生存:一项基于大样本的调查。
BMC Cancer. 2021 Jul 27;21(1):857. doi: 10.1186/s12885-021-08603-z.
8
Could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma?早期卵巢透明细胞癌女性患者是否可考虑保留生育功能手术?
J Gynecol Oncol. 2017 Nov;28(6):e71. doi: 10.3802/jgo.2017.28.e71. Epub 2017 Jul 3.
9
Does omentectomy in epithelial ovarian cancer affect survival? An analysis of the Surveillance, Epidemiology, and End Results database.上皮性卵巢癌行大网膜切除术会影响生存率吗?基于监测、流行病学及最终结果数据库的分析
Int J Gynecol Cancer. 2015 May;25(4):607-15. doi: 10.1097/IGC.0000000000000412.
10
Uterine Clear Cell Carcinoma: Does Adjuvant Chemotherapy Improve Outcomes?子宫透明细胞癌:辅助化疗能否改善预后?
Int J Gynecol Cancer. 2017 Jan;27(1):69-76. doi: 10.1097/IGC.0000000000000839.

引用本文的文献

1
Female urethral diverticular carcinoma: a case report and review of the literature.女性尿道憩室癌:一例报告并文献复习
Front Oncol. 2025 Jan 27;14:1503116. doi: 10.3389/fonc.2024.1503116. eCollection 2024.
2
Current Status and Challenges in Rare Genitourinary Cancer Research and Future Directions.罕见泌尿生殖系统癌症研究的现状与挑战及未来方向。
Curr Oncol Rep. 2024 Sep;26(9):977-990. doi: 10.1007/s11912-024-01554-1. Epub 2024 Jun 7.
3
Clear Cell Adenocarcinoma of Urethra: Clinical and Pathologic Implications and Characterization of Molecular Aberrations.

本文引用的文献

1
Clear Cell Adenocarcinoma of Female Urethra.女性尿道透明细胞腺癌
J Clin Diagn Res. 2017 Jul;11(7):ED01-ED02. doi: 10.7860/JCDR/2017/25261.10127. Epub 2017 Jul 1.
2
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours.《2016 年世界卫生组织泌尿系统及男性生殖器官肿瘤分类-第 B 部分:前列腺和膀胱肿瘤》。
Eur Urol. 2016 Jul;70(1):106-119. doi: 10.1016/j.eururo.2016.02.028. Epub 2016 Mar 17.
3
High-dose-rate brachytherapy - a novel treatment approach for primary clear cell adenocarcinoma of male urethra.
尿道透明细胞腺癌:临床病理意义及分子异常特征。
Cancer Res Treat. 2024 Jan;56(1):280-293. doi: 10.4143/crt.2023.577. Epub 2023 Sep 11.
4
Clear cell adenocarcinoma of the prostatic urethra with metachronous prostate adenocarcinoma.前列腺尿道透明细胞腺癌伴异时性前列腺腺癌
Urol Case Rep. 2023 Jan 30;47:102338. doi: 10.1016/j.eucr.2023.102338. eCollection 2023 Mar.
5
A rare case of a clear cell carcinoma in a female urethral diverticulum.一例罕见的女性尿道憩室透明细胞癌。
IJU Case Rep. 2022 Oct 12;6(1):77-80. doi: 10.1002/iju5.12544. eCollection 2023 Jan.
6
Epidemiology of Unconventional Histological Subtypes of Urethral Cancer.尿道癌非常规组织学亚型的流行病学。
Urol Int. 2023;107(1):15-22. doi: 10.1159/000525673. Epub 2022 Jul 26.
7
Primary clear cell adenocarcinoma of female urinary tract: a case report and literature review.女性泌尿道原发性透明细胞腺癌:一例报告并文献复习。
BMC Womens Health. 2022 Jun 24;22(1):251. doi: 10.1186/s12905-022-01835-6.
高剂量率近距离放射治疗——男性尿道原发性透明细胞腺癌的一种新型治疗方法。
J Contemp Brachytherapy. 2015 Jun;7(3):248-51. doi: 10.5114/jcb.2015.52316. Epub 2015 Jun 15.
4
Clear cell adenocarcinoma of the urethra: review of the literature.尿道透明细胞腺癌:文献综述
Int J Surg Oncol. 2015;2015:790235. doi: 10.1155/2015/790235. Epub 2015 Jan 20.
5
Primary clear cell adenocarcinoma of a urethral diverticulum treated with multidisciplinary robotic anterior pelvic exenteration.采用多学科机器人辅助前盆腔脏器清除术治疗的尿道憩室原发性透明细胞腺癌。
Case Rep Med. 2013;2013:387591. doi: 10.1155/2013/387591. Epub 2013 Dec 23.
6
Primary urethral clear-cell adenocarcinoma: comprehensive analysis by surgical pathology, cytopathology, and next-generation sequencing.原发性尿道透明细胞腺癌:通过外科病理学、细胞病理学和下一代测序进行的综合分析
Am J Pathol. 2014 Mar;184(3):584-91. doi: 10.1016/j.ajpath.2013.11.023. Epub 2014 Jan 3.
7
Clear cell carcinoma of female urethral diverticulum--a case report.女性尿道憩室透明细胞癌 1 例报告。
J Formos Med Assoc. 2013 Aug;112(8):489-91. doi: 10.1016/j.jfma.2012.07.018. Epub 2012 Aug 30.
8
Primary vesical clear cell adenocarcinoma arising in endometriosis: a rare case of mullerian origin.原发性膀胱透明细胞腺癌源于子宫内膜异位症:罕见的苗勒管来源。
Anticancer Res. 2013 Feb;33(2):615-7.
9
A case of clear cell adenocarcinoma arising from the urethral diverticulum: Utility of urinary cytology and immunohistochemistry.一例起源于尿道憩室的透明细胞腺癌:尿液细胞学和免疫组织化学的应用
Cytojournal. 2012;9:11. doi: 10.4103/1742-6413.95528. Epub 2012 Apr 30.
10
Metastatic clear cell adenocarcinoma of the urethra in a male patient: report of a case.男性患者尿道转移性透明细胞腺癌:一例报告
Clin Genitourin Cancer. 2012 Mar;10(1):47-9. doi: 10.1016/j.clgc.2011.10.002. Epub 2011 Nov 6.